Top compounds associated with response to RP11-545J16.1


Feature Type Standardized
Nominal ANOVA
mRNA tandutinib CTRPv2 pan-cancer AAC -0.043 0.3
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA CBB-1007 CTRPv2 pan-cancer AAC -0.064 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA JQ-1:MK-0752 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA clofarabine CTRPv2 pan-cancer AAC 0.034 0.3
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.037 0.3
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC -0.064 0.3
mRNA etoposide CTRPv2 pan-cancer AAC 0.034 0.3
mRNA alvocidib CTRPv2 pan-cancer AAC -0.057 0.3
Download CSV